132 related articles for article (PubMed ID: 33522599)
1. Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with β-thalassaemia.
Oikonomopoulou C; Paisiou A; Komitopoulou A; Ioannidou ED; Kaisari A; Tzannou I; Mpourazani E; Vessalas G; Peristeri I; Kitra-Roussou V; Goussetis E
Br J Haematol; 2021 Mar; 192(5):e127-e129. PubMed ID: 33522599
[No Abstract] [Full Text] [Related]
2. Modified conditioning regimen improves outcomes of unrelated donor peripheral blood stem cell transplantation for β-thalassaemia major patients.
Huang K; Zhou DH; Li Y; Xu HG; Que LP; Chen C; Xue HM; Guo HX; Weng WJ; Huang SL; Fang JP
Pediatr Blood Cancer; 2018 Jul; 65(7):e27026. PubMed ID: 29512932
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature.
Neunert CE; Despotovic JM
Pediatr Blood Cancer; 2019 Apr; 66(4):e27569. PubMed ID: 30537439
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.
Page KM; Mendizabal AM; Prasad VK; Martin PL; Parikh S; Wood S; Sempowski GD; Szabolcs P; Kurtzberg J
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1108-1117. PubMed ID: 18804040
[TBL] [Abstract][Full Text] [Related]
5. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
6. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
7. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Baron F; Mohty M; Blaise D; Socié G; Labopin M; Esteve J; Ciceri F; Giebel S; Gorin NC; Savani BN; Schmid C; Nagler A
Haematologica; 2017 Feb; 102(2):224-234. PubMed ID: 27927772
[TBL] [Abstract][Full Text] [Related]
8. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
Sun L; Wang N; Chen Y; Tang L; Xing C; Lu N; Shi Y; Ma Y; Lin F; Yu K; Feng J
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1592-1596. PubMed ID: 30951841
[TBL] [Abstract][Full Text] [Related]
9. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
[TBL] [Abstract][Full Text] [Related]
10. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
[TBL] [Abstract][Full Text] [Related]
11. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Elliott MA; Nichols WL; Plumhoff EA; Ansell SM; Dispenzieri A; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Micallef IN; Tefferi A; Litzow M
Mayo Clin Proc; 2003 Apr; 78(4):421-30. PubMed ID: 12683694
[TBL] [Abstract][Full Text] [Related]
12. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
14. Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.
Konuma T; Kato S; Ooi J; Oiwa-Monna M; Tojo A; Takahashi S
Ann Hematol; 2015 Feb; 94(2):289-96. PubMed ID: 25178518
[TBL] [Abstract][Full Text] [Related]
15. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation.
Li C; Wu X; Feng X; He Y; Liu H; Pei F; Liao J; He L; Shi L; Li N; Liu Q; Liu S; Chen G; Su Q; Ren Y; Wang Y; Tan W
Blood; 2012 Nov; 120(19):3875-81. PubMed ID: 22968457
[TBL] [Abstract][Full Text] [Related]
16. Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.
Konuma T; Kato S; Ooi J; Oiwa-Monna M; Kawamata T; Tojo A; Takahashi S
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1150-5. PubMed ID: 24727335
[TBL] [Abstract][Full Text] [Related]
17. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
19. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
20. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
Sakellari I; Batsis I; Bousiou Z; Mallouri D; Constantinou V; Gavriilaki E; Smias C; Yannaki E; Kaloyannidis P; Papaioannou G; Stavroyianni N; Syrigou A; Sotiropoulos D; Fylaktou A; Tsompanakou A; Saloum R; Anagnostopoulos A
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):658-666. PubMed ID: 28716402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
